In the western medicine, there are many forms of medicines and therapies that have not yet been formally recognized by major government health organizations like the Food and Drug Administration (FDA). These therapies are also considered quite controversial by health-care workers within our western society. As such, the implications of these medicines from a health/economics view show that insurance agencies have not formally added them to policies. In this documentary, we will explain and analyze the function and purpose of stem cell therapy (STT) injections and the use of biologics, which is defined as the medication produced from our own blood and proteins. We will fill in the gaps with knowledge regarding regenerative medicine, such as the functions and properties of stem cells and its lack of standardization in therapeutics. After providing further knowledge on these topics, we will transition into the health/economic perspective encompassing insurance coverage, government funding, FDA regulation and its potential future.
Details
- Advancements in Stem Cell Research: The Promise and Potential of a Regenerative Future
- Premji, Navid (Author)
- Kantor, Daniel (Co-author)
- Broman, Tannah (Thesis director)
- Stecher, Chad (Thesis director)
- Gruber, Diane (Committee member)
- Barrett, The Honors College (Contributor)
- Department of Supply Chain Management (Contributor)